Banas and colleagues discuss a novel strategy using tumor-specific CRISPR-directed gene editing to overcome chemoresistance by genetic disruption of the transcription factor NRF2. This study characterizes the genetic diversity of CRISPR outcomes in cells and its impact on tumor response in an animal…